Search

Suzanne Marie Noakes

Examiner (ID: 17824)

Most Active Art Unit
1656
Art Unit(s)
1656, 1653
Total Applications
1691
Issued Applications
1090
Pending Applications
193
Abandoned Applications
452

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5815000 [patent_doc_number] => 20060084678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Methods for identifying and using MarR family polypeptide binding compounds' [patent_app_type] => utility [patent_app_number] => 11/296017 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 88 [patent_no_of_words] => 15655 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084678.pdf [firstpage_image] =>[orig_patent_app_number] => 11296017 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/296017
Methods for identifying and using MarR family polypeptide binding compounds Dec 6, 2005 Abandoned
Array ( [id] => 5865500 [patent_doc_number] => 20060099630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'NES-1 polypeptides, DNA, and related molecules and methods' [patent_app_type] => utility [patent_app_number] => 11/292215 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11348 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099630.pdf [firstpage_image] =>[orig_patent_app_number] => 11292215 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/292215
NES-1 polypeptides, DNA, and related molecules and methods Nov 29, 2005 Abandoned
Array ( [id] => 5479617 [patent_doc_number] => 20090202574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'METHODS OF IMMUNE OR HAEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER' [patent_app_type] => utility [patent_app_number] => 11/719736 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 29378 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202574.pdf [firstpage_image] =>[orig_patent_app_number] => 11719736 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/719736
METHODS OF IMMUNE OR HAEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER Nov 17, 2005 Abandoned
Array ( [id] => 5865554 [patent_doc_number] => 20060099684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Novel antiangiogenic peptides' [patent_app_type] => utility [patent_app_number] => 11/263546 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16541 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099684.pdf [firstpage_image] =>[orig_patent_app_number] => 11263546 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/263546
Antiangiogenic peptides Oct 30, 2005 Issued
Array ( [id] => 5613909 [patent_doc_number] => 20060115837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody' [patent_app_type] => utility [patent_app_number] => 11/251227 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 113652 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115837.pdf [firstpage_image] =>[orig_patent_app_number] => 11251227 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/251227
Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody Oct 13, 2005 Issued
Array ( [id] => 5800369 [patent_doc_number] => 20060035336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Prokaryotic collagen-like proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/245689 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15136 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035336.pdf [firstpage_image] =>[orig_patent_app_number] => 11245689 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/245689
Prokaryotic collagen-like proteins and uses thereof Oct 6, 2005 Issued
Array ( [id] => 4808116 [patent_doc_number] => 20080171694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Pharmaceutical Formulation Comprising Crystalline Insulin and Dissolved Insulin' [patent_app_type] => utility [patent_app_number] => 11/664407 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4147 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171694.pdf [firstpage_image] =>[orig_patent_app_number] => 11664407 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/664407
Pharmaceutical formulation comprising crystalline insulin and dissolved insulin Oct 4, 2005 Issued
Array ( [id] => 5304222 [patent_doc_number] => 20090298874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'BACTERIAL ATP SYNTHASE BINDING DOMAIN' [patent_app_type] => utility [patent_app_number] => 11/576023 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 55329 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298874.pdf [firstpage_image] =>[orig_patent_app_number] => 11576023 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576023
Bacterial ATP synthase binding domain Sep 27, 2005 Issued
Array ( [id] => 151580 [patent_doc_number] => 07683032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-23 [patent_title] => 'Deglycosylated and desialidated long pentraxin PTX3' [patent_app_type] => utility [patent_app_number] => 11/575346 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3385 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/683/07683032.pdf [firstpage_image] =>[orig_patent_app_number] => 11575346 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/575346
Deglycosylated and desialidated long pentraxin PTX3 Sep 27, 2005 Issued
Array ( [id] => 5148795 [patent_doc_number] => 20070048855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Variants and chemically-modified variants of phenylalanine ammonia-lyase' [patent_app_type] => utility [patent_app_number] => 11/230374 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 46322 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048855.pdf [firstpage_image] =>[orig_patent_app_number] => 11230374 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/230374
Variants and chemically-modified variants of phenylalanine ammonia-lyase Sep 18, 2005 Issued
Array ( [id] => 5069476 [patent_doc_number] => 20070190578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Method of site specific labeling of proteins and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/228077 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8574 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190578.pdf [firstpage_image] =>[orig_patent_app_number] => 11228077 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/228077
Method of site specific labeling of proteins and uses therefor Sep 15, 2005 Abandoned
Array ( [id] => 5827786 [patent_doc_number] => 20060063149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Compositions and methods for detecting pathogen infection' [patent_app_type] => utility [patent_app_number] => 11/220372 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 36523 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063149.pdf [firstpage_image] =>[orig_patent_app_number] => 11220372 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/220372
Compositions and methods for detecting pathogen infection Sep 5, 2005 Abandoned
Array ( [id] => 425256 [patent_doc_number] => 07271239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'D-isomers of antimicrobial peptide' [patent_app_type] => utility [patent_app_number] => 11/213245 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10614 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/271/07271239.pdf [firstpage_image] =>[orig_patent_app_number] => 11213245 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213245
D-isomers of antimicrobial peptide Aug 25, 2005 Issued
Array ( [id] => 672402 [patent_doc_number] => 07091318 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-15 [patent_title] => 'mmFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/208927 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16268 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/091/07091318.pdf [firstpage_image] =>[orig_patent_app_number] => 11208927 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/208927
mmFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof Aug 21, 2005 Issued
Array ( [id] => 350365 [patent_doc_number] => 07496489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Design of progesterone receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/208303 [patent_app_country] => US [patent_app_date] => 2005-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 82892 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 346 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/496/07496489.pdf [firstpage_image] =>[orig_patent_app_number] => 11208303 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/208303
Design of progesterone receptor ligands Aug 18, 2005 Issued
Array ( [id] => 5924976 [patent_doc_number] => 20060241285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Crystals and structure of Synagis Fab' [patent_app_type] => utility [patent_app_number] => 11/207142 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20281 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241285.pdf [firstpage_image] =>[orig_patent_app_number] => 11207142 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/207142
Crystals and structure of Synagis Fab Aug 16, 2005 Issued
Array ( [id] => 5558266 [patent_doc_number] => 20090269843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Hemopexin fusion proteins' [patent_app_type] => utility [patent_app_number] => 11/660715 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17986 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269843.pdf [firstpage_image] =>[orig_patent_app_number] => 11660715 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/660715
Hemopexin fusion proteins Aug 15, 2005 Abandoned
Array ( [id] => 4484354 [patent_doc_number] => 07869958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-11 [patent_title] => 'Structure-based modulators of B1 G-protein coupled receptors' [patent_app_type] => utility [patent_app_number] => 11/199821 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 32065 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/869/07869958.pdf [firstpage_image] =>[orig_patent_app_number] => 11199821 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/199821
Structure-based modulators of B1 G-protein coupled receptors Aug 8, 2005 Issued
Array ( [id] => 5515320 [patent_doc_number] => 20090215627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Crystal Structure of Biotin Carboxylase (Bc) Domain of Acetyl-Coenzyme a Carboxylase and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/573217 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19112 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215627.pdf [firstpage_image] =>[orig_patent_app_number] => 11573217 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/573217
Crystal Structure of Biotin Carboxylase (Bc) Domain of Acetyl-Coenzyme a Carboxylase and Methods of Use Thereof Aug 2, 2005 Abandoned
Array ( [id] => 5813929 [patent_doc_number] => 20060084090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Modulation of interaction between Nod1 and Gram-negative bacteria by Nod1 response to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (cagPAI)' [patent_app_type] => utility [patent_app_number] => 11/195696 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 19007 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084090.pdf [firstpage_image] =>[orig_patent_app_number] => 11195696 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/195696
Modulation of interaction between Nod1 and Gram-negative bacteria by Nod1 response to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (cagPAI) Aug 2, 2005 Abandoned
Menu